All posts by ilia2014

Longevity Month – October 2021

Longevity Day and Month GenericThe United Nations General Assembly voted to establish October 1st as the ‘International Day of Older Persons’ as recorded in Resolution 45/106. The holiday was observed for the first time on October 1st, 1991.

Following this tradition, longevity research activists from around the world call this day and the month of October; International Longevity Day and International Longevity Month.

Events focused on supporting biomedical research to further understand the biology of aging and extend healthy human lifespan, take place internationally throughout the entire month of October.

Since 2013 hundreds of events have been organized and we hope this tradition will continue and will keep strengthening the longevity advocacy community.

Also in 2021, events have been organized around the world. Though initiated from various specific countries, they are mostly online and thus international, including:

Nigeria

https://www.facebook.com/agbolade.omowole/posts/10226818543560617

Bulgaria

https://www.facebook.com/events/900360290915864?ref=newsfeed

https://www.facebook.com/groups/280389975798657/posts/1209101016260877/

Brazil

https://www.facebook.com/portalterceiraidade/videos/570001527611700

Malaysia

https://www.facebook.com/wteforum/videos/1303709303394949

https://youtu.be/TgwDpW8mFQk?t=297

US

https://www.raadfest.com/

Spain

https://www.transvisionmadrid.com/

India

On the occasion of Longevity Day, 1st October, India Future Society announced an open competition for individuals/organizations to submit applications on the theme of Indo-Futurism.

https://indiafuturesociety.org/call-for-entries-on-indo-futurism/

 

If you organize an event, create a publication, an awareness action, or make any other effort to promote International Longevity Day/Month, we would love to learn about it! You can let us know by emailing us at ila-lead@googlegroups.com

Chronographic Aging Project

By Alexey Olovnikov, PhD

[Published with permission of Dr. Olovnikov in search of support for his work and cooperation]

The essence of the chronographic aging theory, the possibility of its verification and consequences        

The chronographic theory of aging  (Olovnikov A.M. Chronographic theory of development, aging, and origin of cancer: Role of chronomeres and printomeres. Curr Aging Sci. 2015; 8 (1): 76-88) is based on the assumption of a consistent loss by brain’s neurons of their special extra-chromosomal DNA amplificates. They are copies of some regulatory sites of chromosomal DNA. Chromosomal originals of these copies remain virtually intact until the end of the organism’s life. Gradually losing these amplificates from neurons, a body, owing to this process, evaluates the course of endogenous time throughout life. Amplificates in neurons of a brain are designated as chronomeres. Similar amplificates are also present in other, non-neuronal cells, where they are referred to as printomeres. All these amplificates are the double-stranded DNA molecules. They are relatively small perichromosomal copies of their chromosomal originals. The length of chronomeres may be from a few hundred to thousands of nucleotides. Different chronomeres have distinct sequences depending on the specificity of those neurons in which they are located. Each chronomere is aligned “side by side” with its chromosomal original, that is next to it, though extrachromosomally. In other words, each chronomere is represented by an independent separate DNA molecule. Chronomere is fixed on a body of its chromosome like a fish-sticking on shark – in the sense that chronomere uses the chromosome as a physical support. Retention of chronomere on the support is assisted with auxiliary heterochromatin’s proteins. The nucleotide sequence of the chronomere and its chromosomal original (the corresponding regulatory sequence of chromosomal DNA ) are identical. Therefore, chronomere sequences during the routine DNA sequencing remain unnoticed.

Chronomeres and printomeres are involved in maintaince of cellular differentiation, i.e. these perichromosomal organelles participate in the control of cell specificity. But in the brain’s neurons, chronomeres are responsible also for an another specific function: they are part of the life-long clock of a body. In neurons that differ in specificity, chronomeres respectively have distinct DNA sequences. Corresponding neurons, when they sequentially lose their chronomeres, are able to inform the body about its current physiological age: in this manner the neurons do change the properties of innervated body’s targets, i.e. body’s corresponding systems, organs, tissues and cells. That is why the numerous physiological and even anatomical characteristics gradually change in any person over time. Due to the loss of chronomeres by neurons, the body “knows” when, for example, it is the time to implement the puberty, when it is time for menopause or andropause, etc. Chronomere-related lifelong clock, or neuronal chronograph, performs its “ticking” already in the embryo, thus participating in the formation and then in the physiological maturation of the organism. But continuing to “tick” after maturation of his host, chronograph is eventually leading a host to the grave. The smaller the number of chronomeres left in the brain of an old person, the less, ceteris paribus, time is left to live for this human being.

Potential therapeutic uses of chronomeres: In the future, when it will be possible to regenerate chronomeres in an old brain (using as templates their chromosomal originals, which unlike chronomeres do not disappear from neurons), the doctors will be able to literally “twist off the clock back”, i.e. to directly rejuvenate the person. Another alternative is potentially not ruled out also – by slowing the losses of chronomeres it will be possible to get virtually a complete control over the pace of aging. To get such possibilities, it is necessary to perform enough hard work. The first crucial step is to find these amplificates. Only then the search for pharmacological and other means, which allow to control the process of aging, may become possible.

Linear DNA of chronomere has free ends, they are designated as the acromeres, to distinguish them from the telomeres that protect the free ends of the chromosomal DNA. Like telomeres, acromeres should protect its linear chronomeric DNA at its ends from exonucleases. By their nucleotide sequences, acromeres with high probability should have the vertebrate-like telomere repeats. In humans, the acromeres also may have TTAGGG repeats, but the number of such repeates in each acromere are probably much less compared with the long telomeres in the same neurons.

What should be done to identify chronomeres?

One can treat the samples of neuronal nuclear DNA with terminal transferase to add, for example, poly-T to all 3’ ends of DNA. Since the two DNA strands in a linear DNA molecule are antiparallel, the both poly-T tails in any sought-for amplificate (in a chronomere, as well as in a printomere) will be in an inverted orientation in regard to each other. The identification of such structures in the samples of neuronal chromosomes (using all proper controls to exclude occasional DNA breaks) will show the presence and even the locations of the sought-for chronomeres on the surface of chromosomal DNA in neurons.

Next steps – sequencing of identified chronomeres and preparing of catalogues of  chronomeres for humans and laboratory animals. Following this, it will be possible to look for ways to regenerate chronomeres – restoring the aged neurons in vitro and then in the aged brains of animals. Also it will be possible to use some viral vectors armed with chronomeric sequences as an alternative way of neuronal rejuvenation.

A proved absence of the predicted perichromosomal amplificates in neurons would be a complete and unconditional refutation of the chronographic theory of aging. On the contrary, detection of chronomeres will be a pivotal event that will open the straight path to a future victory over numerous age-related pathologies and aging itself.

The key predictions of my former theory concerning cell aging, namely telomere theory, were: i) shortening of telomeres in dividing cells, ii) the existence of a special variant of DNA polymerase (a telomerase in current terminology), which should compensate telomere shortening, and iii) the prediction that this enzyme should be found in cancer cells and in sex cells. All these predictions of mine were confirmed – a quarter of a century later after their publication. The founder of Geron Corporation, Dr. M. West, has noted that this Corporation was organized taking into account the ideas of my telomere theory. The material on this subject can be found, for example, on these websites: http://www.michaelwest.org/Telomeres-as-the-Clock-of-Aging-and-Immortalization.htm ; https://web.archive.org/web/20161026194847/http://www.evidencebasedcryonics.org/2008/10/12/biotimes-quest-to-defeat-aging/    “Dr. West became so convinced of Olovnikov’s theory that he formed a company called Geron to investigate it further. As reported by Life Extension Magazine: “Forty million dollars later,” West recalls, “the gamble paid off.” West’s group had in fact produced Olovnikov’s mysterious enzyme…”

The aging of a body, though it is composed of cells, cannot be explained, however, only through the senescence of individual cells. Chronographic theory refers now to the higher levels of regulation, explaining both cellular aging and, more importantly, the organismal aging. It is not difficult to foresee that a new direction suggested by my chronographic theory of aging also will attract in the future the worldwide attention of scientific institutions and companies. Is it necessary to waste again another decades?

 

Alexey M. Olovnikov,

Moscow,   olovnikov@gmail.com

ILA scientific activities and activities for the advancement of science

ILA Logo - FINAL transparent - White

The main stated aim of the International Longevity Alliance (ILA) is achieving “healthy longevity for all through scientific research” (https://longevityalliance.org/). To promote this aim, ILA acts as an organization for the advancement of longevity science, and its positive social and humanitarian aspects, producing methodological and policy recommendations for the development of longevity science, as well as a dedicated scientific organization producing original research and scientific reviews and summaries on the subject of aging and healthy longevity.

Both as an organization for the advancement of science and a dedicated scientific organization, ILA promotes the research on healthy longevity by ameliorating degenerative aging processes which are the main risk factors for chronic age-related diseases and disabilities. Under this general objective, ILA advances and conducts research into the methodology and practice of aging intervention, in both the diagnostic aspects (exploring biomarkers and other clinical parameters of aging) and therapeutic aspects (exploring potential therapeutic interventions, such as animal experiments and analysing data on human interventions).

Examples of ILA research activities, both as an organization for the advancement of science and a dedicated scientific organization, have been reported in scientific articles, and scientific conferences, as follows.

Several ILA academic publications have included both the policy research (advancement of science) and original research (science per se). For example, the following articles initiated by ILA experts contribute to the methodology of addressing aging as a medical condition, including policy as well as diagnostic and therapeutic aspects:  

Daria Khaltourina, Yuri Matveyev, Aleksey Alekseev, Franco Cortese, Anca Ioviţă. Aging Fits the Disease Criteria of the International Classification of Diseases. Mechanisms of Ageing and Development. 189, 111230, 2020. https://doi.org/10.1016/j.mad.2020.111230

Editorial. Opening the door to treating ageing as a disease. The Lancet Diabetes & Endocrinology. 6 (8), P587, 2018. https://doi.org/10.1016/S2213-8587(18)30214-6

Ilia Stambler. Recognizing degenerative aging as a treatable medical condition: methodology and policy. Aging and Disease. 8(5), 583-589, 2017. https://doi.org/14336/AD.2017.0130

On the other hand, as part of original scientific research, ILA experts (in particular Dr. Edouard Debonneuil, Dr. Dmytro Shytikov and Dr. Anton Kulaga) initiated several test trials of aging-ameliorating (geroprotective) therapies in mice.

The results of ILA-initiated studies of potential geroprotective therapies in mice have been reported in the scientific literature. Thus, a recent study explored the effect of the potential geroprotective drug C60:

Dmytro Shytikov, Iryna Shytikova, Deepak Rohila, Anton Kulaga, Tatiana Dubiley, and Iryna Pishel. Effect of Long-Term Treatment with C60 Fullerenes on the Lifespan and Health Status of CBA/Ca Mice. Rejuvenation Research, 19 May 2021. https://doi.org/10.1089/rej.2020.2403

https://www.indiegogo.com/projects/i-am-a-little-mouse-and-i-want-to-live-longer#/

An additional research study on the use of senolytic drugs for healthy longevity in mice, co-organized by ILA and Leipzig university, is now in the final stages of preparation.

https://web.archive.org/web/20161031103116/http://longevityalliance.org/?q=longevity-activists-call-support-investigation-drugs-against-aging

https://web.archive.org/web/20201026153126/http://longevityalliance.org/?q=mmtpsenolytics-second-dosing-september

A strong focus of ILA scientific activities has been on developing clinical evaluation criteria for aging and aging-related diseases.

For example, ILA experts, a board member and a scientific advisor (Dr. Ilia Stambler and Dr. Alexey Moskalev) initiated, under ILA affiliation, a special research topic on clinical evaluation criteria of aging and aging-related diseases, in the scientific journal Frontiers in Genetics. 9 scientific articles have been published in this research topic by internationally acclaimed scientists, and a summary by the ILA expert editors is forthcoming.

https://www.frontiersin.org/research-topics/14483/clinical-evaluation-criteria-for-aging-and-aging-related-multimorbidity

It is important to emphasize that ILA, though currently head-quartered in France, includes as its federated members the non-profit associations for the promotion of healthy longevity research from around the world. As of July 2021, ILA included 29 non-profit associations from 24 countries as federated members (https://www.longevityforall.org/groups/). The research done by these organizations also contributes to the ILA total scientific contribution as a whole.

For example, the commitment “Quantified Longevity Guide” of the European Innovation Partnership on Active and Healthy Aging (EIP-AHA) is advanced by the ILA federated members Vetek Association – the Movement for Longevity and Quality of Life, and Israeli Longevity Alliance.

https://ec.europa.eu/eip/ageing/commitments-tracker/a3/quantified-longevity-guide-qlg_en.html

Additional commitments in the European Innovation Partnership on Active and Healthy Aging (EIP-AHA) are advanced by the ILA federated members: Longevite & Sante (France) and Gesellschaft für Gesundes Altern und Prävention – (e. V.) (The Society for Healthy Aging and Prevention/HEALES Germany)

https://ec.europa.eu/eip/ageing/commitments-tracker/a3/_en%3Fpage=1.html

And yet some other academic works by ILA experts mainly focus on the advancement of longevity science, via science policy and activism, such as:

Stambler I and Milova E. Longevity activism. In: The Encyclopedia of Gerontology and Population Aging, Springer, 2019, edited by Matthew Dupre and Danan Gu. https://doi.org/10.1007/978-3-319-69892-2_395-1

Stambler I. “The Longevity Movement Building”; “Outreach Materials for Longevity Promotion”. In: Longevity Promotion: Multidisciplinary Perspectives. Longevity History, 2017. ISBN: 1974324265. http://www.longevityhistory.com/longevity-movement-building/ 

In the recent period, ILA experts participated in developing and promoting position papers and other outreach materials focusing specifically on the need to improve the underlying health of older persons to minimize the risks of COVID-19, including:

“Geroscience in the Age of COVID-19”. Aging and Disease. 11(4), 725-729, 2020. https://doi.org/10.14336/AD.2020.0629

https://www.jpost.com/opinion/we-can-do-more-to-help-the-elderly-cope-with-the-covid-19-crisis-642408 

“WHO must prioritise the needs of older people in its response to the covid-19 pandemic”. BMJ. 368:m1164, 2020 

https://doi.org/10.1136/bmj.m1164

https://ifa.ngo/open-letter-to-who-signatures/

https://ifa.ngo/news/open-letter-requesting-action-from-the-who-regarding-covid-19-and-older-people/

We Call for Open Anonymized Medical Data on COVID-19 and Aging-Related Risk Factors

http://chng.it/cLwkxSsP

Furthermore, a large part of ILA activities have promoted science education about healthy longevity research. For example, ILA promoted scientific education on aging and longevity research through the annual educational campaigns “Longevity Month” that ILA has been organizing since 2013.

https://www.longevityforall.org/longevity-month-october-2020/

Another means employed by ILA for the advancement of science and for scientific discussion per se is by organizing scientific and educational conferences. Just since 2020, ILA was the main organizer of 3 high level scientific conferences on aging and aging-related diseases, on line, with the participation of leading international researchers of aging, and co-organized and/or participated in up to 10 more scientific and science-education conferences. The main 3 high level online conferences organized by ILA since 2020 were:

The 1st Metchnikoff’s Day Online Conference “Aging, Immunity and COVID-19”, May 16, 2020. https://web.archive.org/web/20200810154922/http://longevityalliance.org/?q=1st-metchnikoff-s-day-online-conference-aging-immunity-and-covid-19-may-16-2020 . Conference statement 

Eurosymposium on Healthy Ageing, Enhancing clinical trials for longevity therapies, online, October 1, 2021 http://www.eha-heales.org/ .  Conference statement 

Conference and workshops. Clarifying whether and to what degree the current anti-aging approaches work in mice or people, online, February 11, 2021 https://www.longevityforall.org/conference-online-on-anti-aging-testing-11-february-2021/ . Conference statement 

We hope that these activities initiated and conducted by ILA and its experts, both as an organization for the advancement of science and a dedicated scientific organization, will advance the common social benefit of healthy longevity for all through scientific research. We thank you for your support!

ILA board

 

 

ILA general assembly – 6 March 2021

ILA Logo - FINAL transparent - WhiteOn March 6, 2021, the regular annual general assembly of the International Longevity Alliance took place.

The assembly approved the ILA activity report for 2020. 

http://www.longevityforall.org/ila-yearly-report-2020/

The assembly re-elected 3 board members for another 2 years term: Daria Khaltourina – Council for Public Health and Problems of Demography (Russia), Edouard Debonneuil – Longevite & Sante (France), Ilia Stambler – Israeli Longevity Alliance (Israel).

4 board members remain to serve another year of their 2 years term: Maria Entraigues – SENS Research Foundation (US), Walter Crompton – American Longevity Alliance (US), Didier Coeurnelle – AFT Technoprog (France), Alexander Tietz – HEALES (EU).

Additional topics and news:

The International Longevity Alliance (ILA) welcomes its new federated member, the Russian National Academy of Active Longevity! Welcome aboard!

http://antiage-med.ru/

Currently, the ILA includes 25 registered non-profit associations from 21 countries as federated members.

http://www.longevityforall.org/groups/

On March 1, the Israeli Longevity Alliance successfully conducted an online conference on Longevity and Quality of Life. The meeting recording (in Hebrew) is available.

https://www.longevityisrael.org/conference/

On March 12, 14.00 CET, there takes place the panel on longevity organized by the ILA federated member, the Slovenian Society for Vital Life Extension. This is a part of the Digital Transformation in Science, Education and Arts conference, Slovenia. Details and registration:

https://conference.almamater.si/?lang=en

The conference panel on Longevity (“social gerontology”)

https://submission.almamater.si/mobile/#s:64

More announcements about ILA events, website development and other activities are forthcoming.

Looking forward to the active 2021!

ILA yearly report 2020

ILA Logo - FINAL transparent - WhiteThe 2020 was a difficult year for many people and in many regards. Yet, if there is one lesson to be learned from this crisis that most strongly affected the older people, it is the realization of the need to therapeutically treat degenerative aging processes to prevent aging-related ill health as a whole, including both aging-related chronic degenerative non-communicable diseases and communicable infectious diseases for which the older persons are most vulnerable. This has been the mission of the International Longevity Alliance (ILA) and this year emphasized how important it is to advance this mission. 

This year the ILA continued to follow its mission and throughout the year promoted research and advocacy for aging amelioration and healthy longevity. 

Below is a list of some of the works and achievements of the ILA during the year. Thanks to all who were the involved and all who supported this vital mission!

(All ILA archived news)

–  In March 2020, the ILA, Open Longevity, and many other leading longevity organizations, activists and experts created a joint petition for data openness on COVID-19 and aging-related risk factors, which has been distributed and submitted to WHO officials.

http://chng.it/cLwkxSsP 

– Also in March, ILA members massively endorsed the joint petition to World Health Organization – “WHO must prioritise the needs of older people in its response to the covid-19 pandemic”. See: BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1164

https://ifa.ngo/open-letter-to-who-signatures/

https://ifa.ngo/news/open-letter-requesting-action-from-the-who-regarding-covid-19-and-older-people/

–  This year, the mouse test with senolytic treatments started and proceeded in Leipzig University financed from the ILA-collected donations.

 – An article on classification of aging as a disease in the ICD-11 system “Aging Fits the Disease Criteria of the International Classification of Diseases” was published in the scientific journal Mechanisms of Aging and Development, following the inclusion of aging as a modifier of disease into the ICD-11 classification system mainly thanks to the ILA initiative. https://www.sciencedirect.com/science/article/abs/pii/S0047637420300257?via%3Dihub&

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(18)30214-6/fulltext

 – A special research topic was included in the scientific journal Frontiers in Genetics, driven by ILA members and scientific advisors, concerning “Clinical evaluation criteria for aging and aging-related multimorbidity”

https://www.frontiersin.org/research-topics/14483/clinical-evaluation-criteria-for-aging-and-aging-related-multimorbidity

– A position paper “The Urgent Need for International Action for Anti-aging and Disease Prevention’ was published and promoted with the ILA participation

http://www.aginganddisease.org/article/2020/2152-5250/ad-11-1-212.shtml

– Another position paper with the ILA participation “Geroscience in the Age of COVID-19” advocated for the vital need to promote geroscience research, development and application for effectively tackling the COVID-19 crisis and possible future crises resulting from deteriorating health of older persons.

http://www.aginganddisease.org/article/0000/2152-5250/ad-0-0-0-2007060732-1.shtml  

2020 was a challenging year for many of the ILA federated members. Yet their activities were maintained.

– Thus, a reference site of the European Innovation Partnership for Active and Healthy Aging (EIP-AHA), aimed to promote distributed anti-aging tests, was developed in France, by the ILA France branch and federated member “Longévité et Santé”.

https://ec.europa.eu/eip/ageing/reference-sites_en

– The German longevity community of the ILA federated member “The Society for Healthy Aging and Prevention”, due to the pandemic, could not continue their regular activities (local meetings of activists, events in cooperation with fitness centers and retirement homes). However, they were successful in maintaining their non-profit status (important within the German tax system). They also created a new support group to help with repercussions of the Covid-19 pandemic (ExCoronaHilfe https://excoronahilfe.de/).   

– On May 16, in honor of the 175th anniversary of the founder of gerontology – Elie Metchnikoff, the ILA organized the international online conference “The 1st Metchnikoff’s Day Online Conference – Aging, Immunity and COVID-19”. The conference emphasized the importance of enhancing the immune system in older persons, the research topic that goes back to the foundations of gerontology.

– In June, the ILA federated member – the Slovenian Society for Vital Life Extension – organized an international conference on longevity research and advocacy, with the support of ILA and a strong participation of ILA members.

– In July, the ILA members and partners in Bulgaria, including the University of National and World Economy, Sofia, and Bulgarian Academic Simulation and Gaming Association, organized an international online conference with a special focus on longevity research, with the support of ILA and strong participation of ILA members.

– In October, following the tradition since 2013, the ILA organized the International Longevity Day / Longevity Month educational and advocacy campaign in support of longevity research. As physical meetings were difficult to organize this year, a series of online events and promotions took place, including media coverage, involving thousands of participants from around the world.

https://www.facebook.com/LongevityDay

– Among the events with the strongest impact was the Eurosymposium on Healthy Aging that took place online on October 1, and brought together leading international longevity researchers and over 150 participants, and created media coverage. The event was chiefly organized by Healthy Life Extension Society (HEALES) in cooperation with the ILA.

http://www.eha-heales.org/

– Following the conference on October 1st, the Eurosymposium on Healthy Ageing created and distributed a declaration on “Aging biomarkers and clinical tests”.

– As part of the Longevity Month campaign, the International Longevity Alliance organized the first of its kind prize Competition to support longevity activism, advocacy and raising public awareness about longevity research. 11 excellent contributions arrived from around the world – Russia, Germany, Spain, Pakistan, Nigeria, Morocco, India, Brazil, USA. With all the difficulty to select, the winners were announced, and additional commendations provided. Indeed, the aim of this competition was not to “select the best”, but to encourage more longevity activism. The ILA hopes this prize has contributed to this aim and we hope this tradition will continue.

https://www.longevityforall.org/longevity-activism-prize-winners-announced/

 – In October, the ILA federated member – Forbladi Association (Morocco) that joined the ILA this year, launched its project “Longevity Research Support”. It is hoped that this project will help significantly advance longevity research and advocacy in Africa and the Arabic-speaking community.

https://longevity.ma/

– In 2020, the ILA grew to include 23 non-profit associations from 20 countries as federated members.

If you represent a non-profit association from anywhere in the world, you are welcome to submit your application to join the ILA as a federated member, to expand the global support network for longevity research and advocacy. For this and other forms of cooperation, welcome to write to the ILA board: ila-lead@googlegroups.com

– With the technical difficulties experienced by the main ILA site http://www.longevityalliance.org/ by the end of 2020, currently, the ILA is working to develop its new website format, that will include enhanced features for outreach and community building, such as an interactive longevity activists map, a newsletter, auxiliary pages for local activists groups, and more. Currently, the site http://www.longevityforall.org/ serves as an auxiliary site of the ILA.

All the ILA activities show that longevity activism, even in this difficult period, is alive and actively working for its vital mission to build up public support for more longevity science, for a better, more healthy and resilient future for all of us. Hopefully, more longevity activism will be done in the future. And hopefully, more support, both human and other resources, will be given to longevity activism, to enable it to succeed in its mission. 

 ILA board

 

 

 

Conference Online on Anti-Aging Testing – 11 February 2021

 

February 11, 2021. Conference and workshops. Clarifying whether and to what degree the current anti-aging approaches work in mice or people.

 

Conference - ILA- HEALES - February 11

On the occasion of the next online conference to be held on Thursday, February 11, 2021, from 17:00 to 22:00 PM CET (8.00 AM to 1 PM PDT, 11.00 AM to 4 PM EDT),

we will invite renowned scientists to give an overview of effective anti-aging studies performed on mice or rats as well as the most recent tests performed on humans.

You can register here

The complete conference recording


Thursday, 11 February

17:00 – 17:15  Introduction Didier Coeurnelle, Ilia Stambler, Sven Bulterijs

1. Test on mice/ rats: good practices

17:15 – 17:30  Conboy Mike “Resetting Aged Blood to Restore Youth”

17:30 – 17:45 Vera Gorbunova  “ Promoting longevity by improving genome stability “

17:45 – 18:00  Rodolfo Goya  “ Aging and epigenetic rejuvenation”

18:00 – 18:15   Josh Mitteldorf  “interactions among interventions, and why we can’t just test them separately”.

18:15 – 18:25  Pause

2. Test on human: good practices

18:25 – 18:40   Nir Barzilai “TAME (Targeting Aging with Metformin)”

18:40 – 18:55  Harold Katcher “Breakthrough in age reversal with young blood plasma”

18:55 – 19:10  Greg Fahy “Reversal of epigenetic aging and immunosenescence trends in humans” Aging Cell

19:10 – 19:25 Hanadie Yousef (Juvena Therapeutics)  “Harnessing the regenerative secretome of human embryonic stem cells to rejuvenate aged tissues”

19:25 – 19:40  Liz Parrish “Gene therapy to reduce the effects of aging”

19:40 – 19:55 Justin Rebo (BioAge)

19:55 – 20:00 Martin Lipovšek “Slovenian Levine clock project”

20:00 – 20:10 Edouard Debonneuil “Of mice and men: from the Major Mouse Testing Program to the Major Human Testing Program”

20:10 – 20:20 Pause

3. From rats to humans and the other way around? Legal, scientific, technical, and political aspects. concerning Clinical tests

20:20 – 20:35 Mimicking experimentation on rats and humans thanks to A.I.?  Alexander Zhavoronkov, and /or Polina Mamoshina

20:35 – 20:50 . How to  accelerate. Political and legal aspects Didier Coeurnelle

20:50 – 21:05. Have the anti-aging interventions worked? Some lessons from the history of anti-aging experiments on animals and humans. Ilia Stambler

21:05 – 21:15 Pause

4. Discussion about the 3 themes in 3 groups. Goal: one page of thoughts and proposals for each group

21:15 – 22:00 Divided in 3 zoom spaces

Rats Chair Irina Conboy and Marion
Human tests Chair Aubrey de Grey
Political aspects Alexander and Didier

5. Conclusion and goodbye


The next day, Friday, February 12 (8 – 9.30 PM CET)
Finalization of the 3 texts of thoughts and proposals (discussion on line)

This temporary program is subject to change

Longevity activism prize winners announced


ILA - INTERNATIONAL LONGEVITY ALLIANCE - LOGOLongevity activism prize winners announced!

The International Longevity Alliance announces the winners of the first of its kind prize Competition to support longevity activism, advocacy and raising public awareness about longevity research.

A good number of submissions were made from around the world by leading longevity activist organizations and individuals. It was difficult to make the decisions, as all the contributions were excellent and beneficial for the longevity movement worldwide. All were done by dedicated, creative and effective longevity activists and educators. The main prize can be the actual activities performed. Nonetheless, several activism projects were selected. The decisions were mainly based on the awareness impacts that the projects made in the particular areas, people’s involvement, especially during the October Longevity Month campaign, but also taking into account the past record of longevity activism and encouraging activism development for the future. 

And the winners are: 

First prize: Mikhail Batin and Anastasia Egorova – Open Longevity, Russia, for the Longevity School initiative and the longevity documentary and social media initiatives, among their diverse and long-standing longevity activism, advocacy and educational programs, including an annual offline longevity school.

https://openlongevity.org/

https://www.youtube.com/playlist?list=PLNq0DHP78fotiqTG3xRKlfZSwv0Jx1EBK   

Second prize: Andreas Kabus – Longevity Germany, for the advocacy outreach during the Longevity Month. Andreas is representative of several longevity activism and advocacy initiatives and organizations, including the single issue German Health Party. Yet the prize is given not in relation to any particular organization, but for the longevity outreach effort generally.

https://www.youtube.com/watch?v=p7i5E_g4Fjk&feature=youtu.be

Third prize: Jose Cordeiro – Singularity Madrid, Spain, for the organization of longevity month online events and media promotions, especially for the Spanish-speaking community, and the publication of the book The Death of Death, among other diverse and long-standing longevity advocacy, educational and awareness raising projects.

https://www.meetup.com/MadridSingularity/

https://www.eluniversal.com/el-universal/81479/dia-internacional-de-la-longevidad

There were many excellent submissions by activists, including several less familiar actors in the longevity community, who nonetheless showed a significant potential to develop longevity activism, now and for the future. Hence a new prize category was established: “the breakthrough longevity activism prize” for emerging and promising longevity activism projects and actors.

The four winners of the Breakthrough Longevity Activism Prize are:

Aftab Ahmad – Pakistan Aging Research Society and National Academy of Young Scientists, for the events and promotions in Pakistan during the longevity month

https://nays.com.pk/

https://www.facebook.com/PakistanARS

https://www.facebook.com/events/2724286077844939/?active_tab=discussion

Agbolade Omowole — Longevity Nigeria, for the organization of online events and media promotions during the Longevity Month.

https://www.facebook.com/groups/424397067745808

https://www.sunnewsonline.com/every-nation-should-prioritize-public-health-post-covid-19-expert/

Josiah Akinloye — Enlightenment Transhumanist Forum of Nigeria – ETFN, for longevity outreach media content creation. Josiah is an ILA member (as also several other submitters), yet the prize is given not in relation to any particular organization, but for the longevity advocacy and content creation.

https://www.youtube.com/channel/UCv03wmOFXbdMRN5t2zPlCGg   

Youness Erraiba – For Bladi Association, Morocco, for the emerging educational project Longevity Research Support

https://longevity.ma/

In addition, recognition and commendation are given to the other participants:

Avinash Kumar Singh and Sarah Ahamed — India Future Society, India, for the organization of the longevity month online event and publication.

https://indiafuturesociety.org/report-on-online-longevity-day-conference-2020/

Alexander Shishparenok, Russia, for the Open Science – Gerontology educational channel https://www.youtube.com/user/aleksandrshishparek/videos  

Roc Ordman, USA, for the Nutrition Investigator research and education portal  http://www.nutritioninvestigator.org/ 

Tony Bernstein – Portal Terceira Idade, The Third Age Portal, Brazil, for the healthy longevity promotional video.

http://www.portalterceiraidade.org.br/

https://www.youtube.com/watch?v=g_HIcJaNrN8&feature=youtu.be

Congratulations and thanks to all the winners and participants! The aim of this competition was not to “select the best”, but to encourage more longevity activism. We hope this prize has contributed to this aim and we hope this tradition will continue. The competition showed that longevity activism, even in this difficult period, is alive and actively working for its vital mission to build up public support for more longevity science, for a better, more healthy and resilient future for all of us. Hopefully, more longevity activism will be done in the future. And hopefully, more support, both human and other resources, will be given to longevity activism, to enable it to succeed in its mission. 

In the name of the ILA board

Ilia Stambler

Didier Coeurnelle

Longevity month – October 2020

Longevity Day and Month Generic

Following the tradition since 2013, we organize the International Longevity Month campaign that will start on October 1 and continue through October, in support of longevity research and advocacy. You are welcome to organize meeting events (also online), publications and promotions for longevity research in any format and scope that suits you. Such events can help build up the longevity advocacy community and gain public support for it.

Some history of this campaign:

http://www.longevityhistory.com/longevity-day-and-longevity-month/

This year also, events and promotions for this campaign are being organized around the world.

A central event for this year’s Longevity Month Campaign will be the traditional Eurosymposium on Healthy Aging that has been organized by HEALES and its partners, such as the International Longevity Alliance (ILA) and others since 2010. This year the symposium will be held on October 1 online (via zoom). The main theme of the symposium will be “Enhancing clinical trials for anti-aging therapies”.

http://www.eha-heales.org/

Several other online conference are being organized around the world, including: RAAD Festival, Madrid Singularity meetup, India Future Society Longevity Conference and others.

https://www.facebook.com/groups/LongevityConferences

If you take an active part and/or organize events and promotions for the campaign, you are welcome to contact the ILA board, so together we can think of effective synergies.

Thus, if you organize an event or promotion for the Longevity Month, you may consider submitting your candidature to receive the “Longevity Activism and Awareness Prize” for the best event and/or promotion of the campaign. The first prize is $3000, the second prize is $1000. Details:

http://longevityalliance.org/?q=call-and-prize-longevity-activism-and-raising-public-awareness-about-longevity-research

Looking forward to the creative, active and productive Longevity Month!

On behalf of the ILA board

info@longevityalliance.org

http://longevityalliance.org/?q=starting-preparations-longevity-month

Establishing International Multi-Center Collaboration on Antiaging and Disease Prevention

May 15, 2020

On May 15, representatives of 15 research institutions from 13 countries established an International Multi-Center Collaboration on Antiaging and Disease Prevention by signing a memorandum of understanding (MoU).

The collaboration will include representatives from the Institute of Basic Medical Sciences Chinese Academy of Medical Sciences & School of Basic Medicine Peking Union Medical College, China (Dr. Robert Chunhua Zhao); International Society on Aging and Disease, USA (Dr. Kunlin Jin); University of Valencia, Spain (Dr. Antonio Cano); University of Nice, France (Dr. Eric Gilson); University of Palermo, Italy (Dr. Calogero Caruso); Maharishi Markandeshwar Deemed University, India (Dr. Sasanka Chakrabarti); King’s College London, UK (Dr. Georgina Ellison-Hughes); European Academy of Sciences, Arts and Humanities, France (Dr. Ante Glibota); University of Toronto, Canada (Dr.  Armand Keating); University of Hong Kong, China (Dr. Lee Wei Lim); Syktyvkar State University, Russian Federation (Dr. Alexey Moskalev); Inha University, Republic of Korea (Dr. Kyung-Jin Min); University of Macau, China (Dr. Huanxing Su); Vetek (Seniority) – the Movement for Longevity and Quality of Life, Israel (Dr. Ilia Stambler); Karolinska Institutet, Stockholm, Sweden (Dr. Brun Ulfhake). 

This collaboration followed the establishment of the Executive Committee on Anti-aging and Disease Prevention in the framework of Science and Technology, Pharmacology and Medicine Themes under an Interactive Atlas along the Silk Roads, UNESCO. The committee inauguration took place during the 2nd (Beijing) Annual International Biomedical Health Conference and the 1st Academician Forum of Transnational Biomedical Field, in Beijing, on December 16, 2019[1]. The committee members outlined collaboration opportunities among the institutions involved. The resulting international collaboration will focus on Anti-aging and Prevention of both communicable and non-communicable diseases. This will advance an integrative and preventive approach to diseases as it considers aging processes as the major risk factors of both communicable and non-communicable diseases that need to be addressed by prevention and therapy. The recent evidence of the strong risks of unfavorable outcomes among the elderly and frail COVID-19 patients further emphasizes the validity of this approach and the need for international cooperation in this area. [2]

The collaboration will advance international academic research, innovation and knowledge exchange in relation to:

  • Data sharing for research and development around detection, treatment and prevention of degenerative aging and aging-related diseases, their prevalence, risk factors, evaluation criteria and effective counter-measures.
  • Building working groups around strategic areas of antiaging and disease prevention to select diagnostics and interventions for further development.
  • Implementing projects, publications and meetings around risk factor assessment, regulation/policy, education, diagnosis and interventions for antiaging and disease prevention.
  • Creating academic and public awareness about the role of aging and its amelioration in both non-communicable and communicable diseases. Thus, beside the traditional emphasis on the relation of aging and non-communicable diseases such as heart disease, neurodegenerative diseases, diabetes mellitus, cancer, COPD, etc., this collaboration will also advance the understanding about the role of aging processes and their amelioration in communicable diseases, such as COVID-19. The latter goal will include exploring and advancing therapies that show promise to improve the underlying aging processes, such as the immune function of the elderly, e.g. utilizing mesenchymal stem cells.

This collaboration will be open for additional parties to join at any time for the duration of the collaboration. We hope that this collaboration will contribute to finding and deploying effective measures for ameliorating degenerative aging processes and prevention of aging-related diseases threatening the global society.

 

[1] Robert Chunhua Zhao and Ilia Stambler (2020). The urgent need for international action for anti-aging and disease prevention. Aging and Disease, 11(1), 212-215. https://doi.org/10.14336/AD.2019.1230

See also materials at the International Society on Aging and Disease (ISOAD) http://www.isoad.org/

[2] Zikuan Leng, Rongjia Zhu, Wei Hou, Yingmei Feng, Yanlei Yang, Qin Han, …, Ilia Stambler, Lee Wei Lim, Huanxing Su, Alexey Moskalev, Antonio Cano, Sasanka Chakrabarti, Kyung-Jin Min, Georgina Ellison-Hughes, Calogero Caruso, Kunlin Jin, Robert Chunhua Zhao (2020). Transplantation of ACE2- mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging and Disease, 11(2), 216-228. https://doi.org/10.14336/AD.2020.0228

The anniversary of the founder of gerontology – Elie Metchnikoff. Lessons from history and hope for the future

Metchnikoff Picture 1

The recent years marked multiple anniversaries of the founder of gerontology, a foundational figure of modern immunology, aging and longevity science, and of modern medicine generally – Elie Metchnikoff (May 15, 1845 – July 15, 1916). On May 15, 2015, we celebrated the 170th anniversary of his birth, and on July 15, 2016, we marked 100 years since his death. The year 2018 marked 110 years since his Nobel Prize in Physiology or Medicine “in recognition of [the] work on immunity” (the Nobel Lecture was delivered on December 11, 1908). And May 15, 2020, we celebrated the 175th anniversary of his birth. The past decade could be truly declared “The Decade of Metchnikoff”! 

For the proponents of healthy longevity and advocates of aging research, Metchnikoff has a special significance. Metchnikoff is of course known as a pioneering immunologist and microbiologist, a vice director of the Pasteur Institute in Paris, and the Nobel Laureate in Physiology or Medicine of 1908 for the discovery of phagocytosis (a major contribution to the cellular theory of immunity). Yet, he may also be well credited as “the father” of gerontology – the disciplinary term he coined. Both the terms “gerontology” (“the study of aging”) and “thanatology” (“the study of death”) were coined by him in the Etudes On the Nature of Man, published in 1903, which may mark the beginning of these scientific fields.[1] Metchnikoff himself traced the beginning of publicity of his aging and longevity research to his presentation on April 22, 1901, at the Manchester Literary and Philosophical Society, where he “laid out a program of investigations aimed to unravel the problem of aging, the problem that had seemed almost intractable”.[2]

To the present day, his scientific reputation has remained high around the world. In fact, Metchnikoff can be considered a unifying cultural symbol for many nations.

Metchnikoff was either a direct originator or one of the primary researchers for a variety of key aging-ameliorating and life-extending methods, experiments and research programs that are still being followed today.[3] They include in fact the first truly scientific theory of aging and longevity, based on meticulous histological observations and on a model of dynamic behavior of living tissues, in particular showing the critical role of the immune system (phagocytes) and intoxication of intestinal microflora (microbiome) in degenerative aging processes. Metchnikoff also made a foundational contribution to the discussions of the evolutionary theory of aging, in particular regarding the possibility of “programmed aging.” Thanks to him, there began the development of many practical geroprotective means, including probiotic diets, systemic and adjuvant immunotherapy (serum therapy, in particular the use of cytotoxic sera for tissue stimulation), the study of replacement therapy and regenerative therapy.[4]

In view of the immense significance of degenerative aging processes for the emergence of virtually all diseases, both communicable and non-communicable, and in view of the accelerating development of potential means to intervene into and ameliorate these processes for the sake of achieving healthy longevity, Metchnikoff’s pioneering contribution to this field assumes an ever greater global significance. The world is rapidly aging, threatening grave consequences for the global society and economy, while the rapidly developing biomedical science and technology stand in the first line of defense against the potential threat. These two ever increasing forces bring gerontology, describing the challenges of aging while at the same time seeking means to address those challenges, to the central stage of the global scientific, technological and political discourse. At this time, it is necessary to honor Metchnikoff, who stood at the origin of gerontological discourse, not just as a scientific field, but as a social and intellectual movement.

There is a tradition to celebrate the anniversaries of great persons (scientists, artists, writers, politicians, generals) to promote the area of their activity and popularize their ideology. It may be hoped that honoring the anniversary of Metchnikoff can serve to promote and popularize the science and ideology of healthy life extension, including the state level. The “Metchnikoff Day” (held on the day of his birth – May 15) can provide an impulse for organizing topical meetings and conferences, a stimulus for research, and publications in the media, dedicated to Metchnikoff’s legacy and continuation of his life’s work – the study of aging and longevity. This may play a positive role not only for the advancement and popularization of research of aging and healthy longevity, but also for the promotion of optimism, peace and cooperation.

Indeed, in 2015, events in honor of the Metchnikoff Day were held in Ukraine, Russia, UK, Israel, Cyprus.[5]  In the year 2020, an international online conference was dedicated to Metchnikoff’s 175h anniversary, entitled “Aging, Immunity and COVID-19”.[6]  Unfortunately, the anniversary received little attention among the “main-stream” media and officials, virtually none in 2020. It has been mainly up to researchers and advocates for healthy longevity to create exemplary promotional events and publications in honor of the founder of their movement.

It may be hoped that, following these examples, more events and publications will be held around the world in honor of this day in the future. It is possible to dedicate additional special days to organize internationally coordinated actions and educational campaigns in support of longevity science. Thus, from 2013 through 2019, such actions were organized on or around October 1 – “The International Day of Older Persons” or “The International Longevity Day” with events and actions sometimes expanding through the entire month of October, in the framework of “the Longevity Month” campaign.[7] Yet, “Metchnikoff’s day” on May 15, can be one of the most unifying, uplifting and educational.

Thus thanks to Metchnikoff’s continuing inspiration and authority, the interest in aging and longevity research can be increased in all the walks and segments of society. And thanks to the increased interest and education, the research itself may intensify, producing an improved capacity to contribute to the achievement of healthy longevity for all.

Consider, for example, several statements by Metchnikoff that can inspire thought and action even now. As he stated in Etudes on the Nature of Man (1903, p. 201):[1]

“It has been long noted that aging is very similar to disease. Therefore it is not surprising that human beings feel a strong aversion to aging. … Undoubtedly, it is a mistake to consider aging as a physiological phenomenon. It makes as much sense to accept aging as a normal phenomenon, because everybody ages, as it makes sense to accept childbirth pain as normal, because only very few women are spared it. In both cases, we deal, of course, with pathological and not with purely physiological phenomena. Inasmuch as people endeavor to mitigate or eliminate the pains of a woman in labor, it is as natural to endeavor to eliminate the evils brought by aging. However, while during childbirth pains, it is enough to apply an anesthetic, aging is a chronic evil against which it is much more difficult to find a cure.”

And as he asserted in Forty Years in Search of a Rational Worldview (1914):[8]

“The second of Bergson’s questions “What are we doing in this world?” should be formulated differently: “What should we do in this world?” Our answer to this, presented in this work and elsewhere, can be stated as follows: “We should, by all means, strive that people, ourselves included, live their full life cycle in harmony of feeling and of mind, until reaching, in the ripest old age, a sense of saturation with life. The main misfortune on earth is that people do not live to that limit and die prematurely.” This statement is the basis of all moral actions… It is difficult to imagine that, in some more or less distant future, science will not accomplish this goal and will not solve the problem of the prolongation of human life to a desired limit, as well as rectify other disharmonies of the human nature.

Can there be a stronger call to thought and to action for the combat of degenerative aging and for the prolongation of healthy human life? Let us hope this call will continue to be heard and acted upon.[9]

The recent time further accentuated the importance and relevance of this call. The recent global crisis, with the world held in the grip of the COVID-19 mostly affecting the frail and elderly, showed with unprecedented clarity to vast masses people the importance of fighting against aging-related ill health and for the extension of healthy longevity, for the benefit of the individual and the entire society. Thus, this pandemic of aging-related ill health yet again stressed the importance of Metchnikoff’ legacy and the need to advance and practically implement gerontological science.

Metchnikoff’s anniversary provides yet another opportunity to reflect on the progress gerontologicial science has made since its inception by Metchnikoff about 120 years ago. Many observational and computational techniques, experimental models and theories of aging have been created. Yet it also gives us pause to think how little practical gerontological medical solutions have actually reached the general public to address the urgent challenges of the aging society. Now, 120 years since the start of the field, no verifiable medical means exist to extend either the lifespan or the healthspan in humans, neither the human lifespan nor  the relative healthspan are increasing, only a few biomedical interventions into aging are barely beginning to enter human trials (some of the most notable of them, such as metformin and rapamycin, have been known for many decades), there is no agreed clinically applicable definition of aging or aging-related ill health, nor agreed evidence based measures or evaluation criteria to assess the effectiveness of interventions against these conditions. The specific clinical requirements and regimens of the elderly are barely examined and addressed, even for traditional lifestyle interventions that have been known for centuries (such as diet, exercise and rest), and even those known interventions are often disregarded.

The urgent need to extend healthy longevity, the promise of emerging biomedical technologies, as well as the realization of the little practical solutions achieved so far, may give us all a triple motivation to advance and support gerontological research, to implement it in practice, so it could live up to its promise and necessity. Let us hope no more time will be lost, and urgent research and practical actions will be undertaken, so that we can celebrate Metchnikoff’s next anniversaries with verified extended healthy longevity for the entire global population.

References

[1] I.I. [Ilya Ilyich] Metchnikoff, Etudy o Prirode Cheloveka (Etudes On the Nature of Man), Izdatelstvo Academii Nauk SSSR (The USSR Academy of Sciences Press), Moscow, 1961 (1903). The first French edition, Elie Metchnikoff, Études sur la Nature Humaine, was published in Paris (Masson) in 1903. The Russian translation used here was done by Elie Metchnikoff and his wife Olga.

The book is also available in English: The Nature of Man: Studies in Optimistic Philosophy, translated by P.C. Mitchell, Putnam, NY, 1908 (1903), https://archive.org/details/prolongationofli00metciala.

Unless otherwise specified, all the excerpts quoted here are translated by Ilia Stambler.

[2]  Elie Metchnikoff, “Borba so Starcheskim Pererozhdeniem” (The struggle against the degeneration of senescence), in I.I. Metchnikoff. Sobranie Sochineniy (Collected Works), Eds. N.N. Anichkov and R.I. Belkin, The USSR Academy of Medical Sciences, Moscow, 1962, vol. XV, pp. 346-350.

[3] Ilia Stambler, “Elie Metchnikoff – the founder of longevity science and a founder of modern medicine: In honor of the 170th anniversary,” Advances in Gerontology, 28(2), 207-217, 2015 (Russian); 5(4), 201-208, 2015 (English). 

[4] Ilia Stambler, A History of Life-Extensionism in the Twentieth Century, Longevity History, 2014, http://www.longevityhistory.com/.

[5] Ilia Stambler, “The 170th anniversary of Elie Metchnikoff – the founder of gerontology, May 15, 2015,” Longevity for All, http://www.longevityforall.org/170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-may-15-2015/http://hplusmagazine.com/2015/05/06/may-15-2015-170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-an-opportunity-to-promote-aging-and-longevity-research/

[6] The 1st Metchnikoff’s Day Online Conference “Aging, Immunity and COVID-19” May 16, 2020. http://www.longevityalliance.org/?q=1st-metchnikoff-s-day-online-conference-aging-immunity-and-covid-19-may-16-2020 ;  http://www.longevityforall.org/metchnikoff-day-may-15-online-conference-may-16/

[7] Ilia Stambler, “Longevity Day and Longevity Month” Longevity History, 2019 http://www.longevityhistory.com/longevity-day-and-longevity-month/

[8] Elie Metchnikoff, Sorok Let Iskania Razionalnogo Mirovozzrenia (Forty Years in Search of a Rational Worldview), 1914, in I.I. Metchnikoff, Academicheskoe Sobranie Sochineniy (Elie Metchnikoff. Academic Collected Works, Ed. G.S. Vasezky), Academia Medizinskikh Nauk SSSR (The USSR Academy of Medical Sciences), Moscow, 1954, vol. 13, pp. 9-22.

[9] Ilia Stambler. Marking the 175th Years Anniversary of Elie Metchnikoff – The founder of gerontology and cell immunology – May 15, 2020. The lessons from history and hope for the future. Presentation.

Some of the events in honor of Metchnikoff’s 175th anniversary

The 1st Metchnikoff’s Day Online Conference “Aging, Immunity and COVID-19” May 16, 2020, an event by International Longevity Alliance. 

http://www.longevityforall.org/metchnikoff-day-may-15-online-conference-may-16/

https://longevityalliance.org/new/the-1st-metchnikoffs-day-online-conference-aging-immunity-and-covid-19-may-16-2020/

CONFERENCE RECORDING

https://youtu.be/oDqCYjT1pkA

 

https://www.facebook.com/Elie-Metchnikoff

Програмка_Опарин_обложка_Page1
Третій З’їзд істориків медицини України. 10-11 грудня. Харків. 2020 р.
У тому числі: ІЛЛЯ МЕЧНИКОВ – ЗАСНОВНИК ГЕРОНТОЛОГІЇ
Третий съезд историков медицины Украины. С международным участием (онлайн). Декабрь 10-11, 2020
Включая – Илья Мечников – основатель геронтологии
The third congress of the historians of medicine of Ukraine. Including international participation (online). December 10-11, 2020

 Including: Elie Metchnikoff – the founder of gerontology

Тезисы съезда – в специальном выпуске 14(2Б) журнала:

Восточноевропейский журнал внутренней и семейной медицины

СХІДНОЄВРОПЕЙСЬКИЙ ЖУРНАЛ ВНУТРІШНЬОЇ ТА СІМЕЙНОЇ МЕДИЦИНИ

Conference proceedings – in the Special Issue 14(2B), 2020 of the journal:

The East Europe Journal of Internal and Family Medicine.

In English 

Ilya Mechnikov — the founder of Gerontology.

In Ukrainian 

Ілля Мечников – засновник геронтології.

In Russian

Илья Мечников — основатель геронтологии.

The East Europe Journal of Internal and Family Medicine – 14-2b-2020

https://drive.google.com/file/d/1RMPFe3cmT5P3C6957qoyCvROAxwREOAu/view

Congress Program

Program 3rd congress of historians of medicine Ukraine

The Ukrainian national forum of immunologists, allergologists, microbiologists and specialists in internal medicine, in honor of the 175th anniversary of Elie Metchnikoff.
September 16-17. 2020. Kharkov (also on line)
Including: 175th anniversary of Elie Metchnikoff – the founder of Gerontology and Cell Immunology. Lessons of the Past – Hope for the Future.
ДРУГИЙ НАЦІОНАЛЬНИЙ ФОРУМ ІМУНОЛОГІВ, АЛЕРГОЛОГІВ, МІКРОБІОЛОГІВ ТА СПЕЦІАЛІСТІВ КЛІНІЧНОЇ МЕДИЦИНИ, ПРИСВЯЧЕНИЙ 175-РІЧЧЮ З ДНЯ НАРОДЖЕННЯ І.І. МЕЧНИКОВА» (за участю міжнародних спеціалістів – online)
У тому числі: 175 РОКІВ ВІД ДНЯ НАРОДЖЕННЯ І.І. МЕЧНИКОВА – ЗАСНОВНИКА ГЕРОНТОЛОГІЇ ТА КЛІТИННОЇ ІМУНОЛОГІЇ. УРОКИ МИНУЛОГО – НАДІЯ НА МАЙБУТНЄ.
Ілля Стамблер (Ізраїль). 17 вересня. 2020

 Четвертий З’їзд істориків медицини України. 3-4 листопада. Харків. 2021 р.

У тому числі: І. Стамблер. Розвиток біомедичної геронтології в Україні – історичний пріоритет.
Четвертый съезд историков медицины Украины. С международным участием (онлайн). Ноябрь 3-4, 2021
Включая: И. Стамблер. Развитие биомедицинской геронтологии в Украине – исторический приоритет
The third congress of the historians of medicine of Ukraine. With international participation (online). November 3-4, 2021
Including: I. Stambler. The development of biomedical gerontology in Ukraine – a historical priority
Stambler I. The development of biomedical gerontology in Ukraine – a historical priority. The East Europe Journal of Internal and Family Medicine, 17(2b), 35-40, https://dx.doi.org/10.15407/internalmed2021.02b.035

Metchnikoff day – May 15. Online conference – May 16

Metchnikoff Day Poster 1

The 1st Metchnikoff’s Day Online Conference 

“Aging, Immunity and COVID-19”

May 16, 2020

Via ZOOM

Time (tentative, may be updated): 8am PST, 11am EST,  15pm GMT, 17pm CET, 18 pm IST/MST.

The online conference is dedicated to celebrating the 175th anniversary of Elie Metchnikoff, the founder of gerontology and cell immunology (May 15, 1845-July 15, 1916). The conference will foster academic and public discussion on how biological research of aging and longevity could help tackle COVID-19 pandemics and improve the control of aging-related communicable and non-communicable diseases. 

We will advocate for the strong enhancement of the research of aging-mediated immune deficiency as a major risk factor for disability and mortality. It is established that elders have a much greater risk of dying from COVID-19 than young people. While the average mortality rate from COVID-19 among known cases in Hubei, China, was 0.2% until the age of 40 y.o., it was 14.8% among people over 80 y.o. COVID-19 is thus a disease opportunistically associated with aging. Hence ameliorating degenerative aging processes appears to be the most promising way to protect patients, especially the elderly, to reduce their disability and mortality. 

The conference will emphasize this connection. The International Longevity Alliance holds annual events on Metchnikoff’s Day to promote longevity research and advocacy around the world. 

Attendance is open and free, yet registration is requested.

Registration form (ZOOM link will be sent to the registered attendants in advance).

https://docs.google.com/forms/d/e/1FAIpQLSfdmp_2Uhp7ZYQRRAwu604I0s_g3B8A9QpeFG-Roaboh3CElA/viewform

In addition, the conference will be streamed on facebook, from the ILA group

https://www.facebook.com/groups/longevity.alliance/

The recording is on youtube

https://youtu.be/oDqCYjT1pkA

The Program

http://www.longevityalliance.org/?q=1st-metchnikoff-s-day-online-conference-aging-immunity-and-covid-19-may-16-2020

METCHNIKOFF CONFERENCE PROGRAM MAY 16

Facebook event

https://www.facebook.com/events/237031744174376/

Event poster

https://www.facebook.com/InternationalLongevityAlliance/photos/rpp.308167409309579/2752709588188670/?type=3&theater

See also events and materials from Metchnikoff’s day celebrations in 2015, on Metchnikoff’s 170th anniversary

http://www.longevityforall.org/170th-anniversary-of-elie-metchnikoff-the-founder-of-gerontology-may-15-2015/

Presentations for Metchnikoff’s 175th anniversary

English

Russian

 

We Call for Open Anonymized Medical Data onCOVID-19 and Aging-Related Risk Factors

Open Data on COVID19We hereby call on WHO and country leaders for maximum openness of medical data from patients with the coronavirus SARS-CoV-2, to enhance medical research and the development of new therapies and treatment regimens against this world-threatening disease. Especially, we demand more research and development to therapeutically address aging as the main contributing factor for disability and deaths in this disease, for example to improve the immunity in older people. Data openness is necessary to facilitate such research and achieve safe, effective and accessible therapies, as soon as possible, to combat COVID-19 and other diseases that have aging as the main risk factor. Support this initiative! Sign the petition!

http://chng.it/cLwkxSsP 

 

The full text of the petition can also be found in the links:

Open Longevity: http://eng.openlongevity.org/open_letter_to_who_covid19

International Longevity Alliance (ILA): http://www.longevityalliance.org/?q=we-call-open-anonymized-medical-data-covid-19-and-aging-related-risk-factors

Please share on Facebook